RBF Capital’s Trinity Biotech TRIB Stock Holding History

RBF Capital’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,978	Closed	-$25K	–	394
2019 Q2	$25K	Sell	2,978 -22	-0.7%	-$262	﹤0.01%	388
2019 Q1	$43K	Hold	3,000	–	–	0.01%	378
2018 Q4	$34K	Hold	3,000	–	–	﹤0.01%	396
2018 Q3	$60K	Hold	3,000	–	–	0.01%	397
2018 Q2	$75K	Hold	3,000	–	–	0.01%	373
2018 Q1	$77K	Hold	3,000	–	–	0.01%	358
2017 Q4	$77K	Hold	3,000	–	–	0.01%	359
2017 Q3	$84K	Hold	3,000	–	–	0.01%	349
2017 Q2	$90K	Hold	3,000	–	–	0.01%	336
2017 Q1	$89K	Hold	3,000	–	–	0.01%	341
2016 Q4	$104K	Hold	3,000	–	–	0.01%	340
2016 Q3	$198K	Hold	3,000	–	–	0.03%	295
2016 Q2	$170K	Hold	3,000	–	–	0.03%	300
2016 Q1	$175K	Hold	3,000	–	–	0.03%	299
2015 Q4	$176K	Hold	3,000	–	–	0.03%	308
2015 Q3	$172K	Hold	3,000	–	–	0.04%	283
2015 Q2	$271K	Hold	3,000	–	–	0.05%	251
2015 Q1	$289K	Hold	3,000	–	–	0.06%	209
2014 Q4	$263K	Hold	3,000	–	–	0.05%	215
2014 Q3	$274K	Hold	3,000	–	–	0.06%	204
2014 Q2	$345K	Hold	3,000	–	–	0.08%	190
2014 Q1	$363K	Hold	3,000	–	–	0.09%	178
2013 Q4	$377K	Hold	3,000	–	–	0.09%	180
2013 Q3	$326K	Hold	3,000	–	–	0.09%	185
2013 Q2	$253K	Buy	+3,000	New	+$249K	0.07%	207

Other funds holding TRIB

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ARM

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

RBF Capital's TRIB Position: Q3 2019 in Review

RBF Capital sold out of Trinity Biotech (TRIB) in Q3 2019, closing a stake of 2,978 shares — an estimated $25K sold.

RBF Capital first reported a position in TRIB in Q2 2013 and held it in 25 quarters. The position peaked at $377K in Q4 2013. 29 funds tracked by Wall St. Rank hold TRIB as of Q3 2019.

RBF Capital reported no remaining Trinity Biotech position as of Q3 2019 after selling out during the quarter.
RBF Capital sold 2,978 Trinity Biotech shares in Q3 2019, an estimated $25K.
RBF Capital first reported a position in Trinity Biotech in Q2 2013 and held it in 25 quarters.
RBF Capital's Trinity Biotech position peaked at $377K in Q4 2013.
29 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2019.

Based on RBF Capital's 13F filing for Q3 2019, filed 13 Nov 2019.